Patent · US Active

Methods of treating melanoma with S-equol

US12064413B2 · kind B2 · utility

0Cited by
5References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 15, 2022
Grant dateAug 20, 2024
Priority date
Expiry dateAug 15, 2042

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K16/2827
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides methods and compositions for treating or preventing melanoma with S-equol. The S-equol may be administered alone or in combination with one or more cytotoxic or immunotherapeutic compound or molecule.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.